Corrigendum to: "An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs" [J Hepatol 75 (2021) 572-581]
J Hepatol. 2023 Apr;78(4):883.
doi: 10.1016/j.jhep.2022.12.001.
Epub 2023 Jan 11.
1 Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
2 Genome Medical Science Project, National Center for Global Health and Medicine (NCGM), Tokyo, Japan.
3 Clinical Research Center, National Hospital Organization, Nagasaki Medical Center, Omura, Japan.
4 Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
5 Human Biosciences Unit for the Top Global Course Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Kyoto, Japan; Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
6 Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai Institute of Digestive Disease, Shanghai, China.
7 Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China; Affiliated Hospital of Qingdao University and Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University, Qingdao, China.
8 Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
9 Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
10 Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
11 Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.
12 Regeneron Genetics Center, Tarrytown, New York, USA.
13 Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
14 Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.
15 Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA.
16 Toronto Centre for Liver Disease, Division of Gastroenterology and Hepatology, University of Toronto, Toronto, Ontario, Canada.
17 University of California, Davis, California, USA.
18 Departments of Medicine, Immunology and Medical Sciences, University of Toronto, Toronto, Ontario, Canada; Mount Sinai Hospital, Lunenfeld-Tanenbaum Research Institute and Toronto General Research Institute, Toronto, Ontario, Canada.
19 Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom. Electronic address: gfm26@cam.ac.uk.